May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
In vitro and in vivo Inhibition of Herpes Simplex Virus Infection by Cationic Beta-Peptides
Author Affiliations & Notes
  • C. R. Brandt
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Ophthal & Visual Sci,
  • R. Akkarawongsa
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Ophthal & Visual Sci,
  • T. Potocky
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Chemistry,
  • E. English
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Chemistry,
  • S. Gellman
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Chemistry,
  • Footnotes
    Commercial Relationships  C.R. Brandt, None; R. Akkarawongsa, None; T. Potocky, None; E. English, None; S. Gellman, None.
  • Footnotes
    Support  AI52089, EY07336, EY016665, GM56414, Research to Prevent Blindness, Inc.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 4489. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. R. Brandt, R. Akkarawongsa, T. Potocky, E. English, S. Gellman; In vitro and in vivo Inhibition of Herpes Simplex Virus Infection by Cationic Beta-Peptides. Invest. Ophthalmol. Vis. Sci. 2008;49(13):4489. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Cationic α-peptides block HSV-1 in culture and animal models. Peptides made of β-amino acids are resistant to proteases and are structurally more constrained at shorter lengths. The goal was to test cationic β-peptides in culture and a murine model of HSV keratitis.

Methods: : Activity in Vero cells was tested using a β-gal expressing reporter virus (hrR3). Peptides were added at various times before and after infection to determine the step that is blocked. Toxicity was tested using MTS assays. Efficacy in vivo was tested by post-infection treatment and prophylactically by pre-treating corneas with peptide in 2% methylcellulose.

Results: : The peptides were not toxic up to 50 µM. Amongst the 3 peptides, the one with the strongest 14-helical propensity and globally amphiphilic was most active (EC50 3.0 µM). The peptides were not virucidal, did not block attachment, were not active post-infection, and did not induce cellular resistance to infection. The β-peptides inhibited entry (EC50 3.0 µM). The most active peptide was active when used before infection but was ineffective when topically applied post-infection.

Conclusions: : Cationic β-peptides are selective inhibitors of HSV-1 entry and show in vivo efficacy similar to cationic α-peptides such as θ-defensins. Further studies of cationic β-peptides as potential antiviral agents are warranted.

Keywords: herpes simplex virus • antiviral drugs • keratitis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×